In vivo induced antigen technology (IVIAT)

In vivo induced antigen technology (IVIAT) is a technique that identifies pathogen antigens that are immunogenic and expressed in vivo during human infection. IVIAT is complementary to other techniques that identify genes and their products expressed in vivo. Genes and gene pathways identified by IVIAT may play a role in virulence or pathogenesis during human infection, and may be appropriate for inclusion in therapeutic, vaccine or diagnostic applications.

[1]  J. Hillman,et al.  In vivo induced antigenic determinants of Actinobacillus actinomycetemcomitans. , 2004, FEMS microbiology letters.

[2]  M. Asaduzzaman,et al.  The Major Subunit of the Toxin-Coregulated Pilus TcpA Induces Mucosal and Systemic Immunoglobulin A Immune Responses in Patients with Cholera Caused by Vibrio cholerae O1 and O139 , 2004, Infection and Immunity.

[3]  Bhupinder Bhullar,et al.  Self-Assembling Protein Microarrays , 2004, Science.

[4]  Young Ran Kim,et al.  Characterization and Pathogenic Significance of Vibrio vulnificus Antigens Preferentially Expressed in Septicemic Patients , 2003, Infection and Immunity.

[5]  M. Asaduzzaman,et al.  Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Hillman,et al.  Identification of Candida albicans genes induced during thrush offers insight into pathogenesis , 2003, Molecular microbiology.

[7]  S. Faruque,et al.  ToxR regulon of Vibrio cholerae and its expression in vibrios shed by cholera patients , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Hillman,et al.  In vivo expression of bacterial genes during human infections. , 2003, Methods in molecular medicine.

[9]  J. Hillman,et al.  Genes of periodontopathogens expressed during human disease. , 2002, Annals of periodontology.

[10]  Andrew Camilli,et al.  In Vivo Expression Technology , 2002, Infection and Immunity.

[11]  B S Srivastava,et al.  Selective identification of new therapeutic targets of Mycobacterium tuberculosis by IVIAT approach. , 2002, Tuberculosis.

[12]  Johannes Söllner,et al.  Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Brady,et al.  IVIAT: a novel method to identify microbial genes expressed specifically during human infections. , 2000, Trends in microbiology.

[14]  D. Low,et al.  Assessment of bacterial pathogenesis by analysis of gene expression in the host. , 2000, Annual review of genetics.

[15]  J. Staab,et al.  Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. , 1999, Science.

[16]  M. Whiteway,et al.  Reduced pathogenicity of a Candida albicans MAP kinase phosphatase (CPP1) mutant in the murine mastitis model , 1998, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[17]  S. L. Chiang,et al.  Use of signature‐tagged transposon mutagenesis to identify Vibrio cholerae genes critical for colonization , 1998, Molecular microbiology.

[18]  S Falkow,et al.  Fluorescence-based isolation of bacterial genes expressed within host cells. , 1997, Science.

[19]  M. Arisawa,et al.  Biochemical and genetic characterization of Rbf1p, a putative transcription factor of Candida albicans. , 1997, Microbiology.

[20]  G. Fink,et al.  Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Amara,et al.  Analysis of a genomic DNA expression library of Mycobacterium tuberculosis using tuberculosis patient sera: evidence for modulation of host immune response , 1996, Infection and immunity.

[22]  J. Mekalanos,et al.  Use of recombinase gene fusions to identify Vibrio cholerae genes induced during infection , 1995, Molecular microbiology.

[23]  J. Shea,et al.  Simultaneous identification of bacterial virulence genes by negative selection. , 1995, Science.

[24]  J. Mekalanos,et al.  Use of genetic recombination as a reporter of gene expression. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[25]  MJ Mahan,et al.  Selection of bacterial virulence genes that are specifically induced in host tissues , 1993, Science.

[26]  J. Mekalanos.  Environmental signals controlling expression of virulence determinants in bacteria , 1992, Journal of bacteriology.

[27]  M. Levine,et al.  Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans , 1988, The Journal of experimental medicine.

[28]  N. Pedersen,et al.  Immunochemical characterization of and isolation of the gene for a Borrelia burgdorferi immunodominant 60-kilodalton antigen common to a wide range of bacteria , 1988, Infection and immunity.

[29]  V. L. Miller,et al.  Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Skalka,et al.  In situ immunoassays for translation products. , 1979, Methods in enzymology.

[31]  A. Skalka,et al.  In situ immunoassays for gene translation products in phage plaques and bacterial colonies. , 1976, Gene.